Dingdong (Cayman) (NYSE:DDL) Bolsa

Dingdong (Cayman)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

Dingdong (Cayman) Limited American Depositary Shares (each two representing three Ordinary Shares)

Dingdong (Cayman) Ltd

WisdomTree Dynamic International SmallCap Equity Fund

Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) is currently in Phase 10 of its 18-phase Adhishthana Cycle. With this phase scheduled to end in September 2025, the stock remains within its bullish structure. If that structure holds, the peak is likely to form in Phase 11, the classic culmination point of the Adhishthana Himalayan formation.
<h3 class="wp-block-heading">The Gap-Up Move &amp; Current Phase: Technical and Structural Alignment</h3>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="814" height="522" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01101105/ALNY-Stock-Weekly-Chart.png" alt="Fig.1 ALNY Stock Weekly Chart (Source: Adhishthana.com Reports)" class="wp-image-15137" style="width:524px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01101105/ALNY-Stock-Weekly-Chart.png 814w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01101105/ALNY-Stock-Weekly-Chart-300x192.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01101105/ALNY-Stock-Weekly-Chart-768x493.png 768w" sizes="(max-width: 814px) 100vw, 814px" /><figcaption class="wp-element-caption">Fig.1 ALNY Stock Weekly Chart (Source: Adhishthana.com Reports)</figcaption></figure>
On June 24, ALNY gapped up by more than 30% after announcing that its drug Vutrisiran, used to treat transthyretin amyloid cardiomyopathy, delivered successful results. While the headline reason was fundamental, under the Adhishthana lens, this wasn't a random event.
The stock was in Phase 9 at the time, a phase known for triggering supreme moves and powerful shifts in structure. Phase 9 is also where the stock typically breaks out of its Adhishthana Cakra and begins forming the Himalayan structure. That's exactly what happened here. The gap-up and event aligned itself with the principles, both in sentiment and in form. Now in Phase 10, the stock is continuing its upward trajectory, holding firmly within a bullish stance.
<h3 class="wp-block-heading">Peak Formation Timing: Phase 10 Still in Play</h3>
According to the Adhishthana Principles, peak formation in Phase 10 generally occurs between the 18th and 23rd bars of the phase. ALNY, however, has yet to show any signs of a peak, suggesting the structure is still building. (Ref Fig 1)
As long as this setup remains intact, Phase 11 is likely to host the eventual peak followed by a correction.
<h3 class="wp-block-heading">Monthly Chart Insights: Cakra Formation and Nirvana Level</h3>
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="594" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01101605/ALNY-Cakra-Formtaion-Monthly-Adhishthana--1024x594.png" alt="Fig.2 ALNY Stock Monthly Chakra Formation (Source: Adhishthana.com Reports)" class="wp-image-15141" style="width:529px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01101605/ALNY-Cakra-Formtaion-Monthly-Adhishthana--1024x594.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01101605/ALNY-Cakra-Formtaion-Monthly-Adhishthana--300x174.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01101605/ALNY-Cakra-Formtaion-Monthly-Adhishthana--768x446.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/01101605/ALNY-Cakra-Formtaion-Monthly-Adhishthana-.png 1196w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Fig.2 ALNY Stock Monthly Chakra Formation (Source: Adhishthana.com Reports)</figcaption></figure>
On the monthly timeframe, ALNY is currently in Phase 6, a phase associated with the creation of the Nirvana level, which acts as both a value barometer and a magnet during future bearish periods.
The Nirvana level is yet to be finalized but will be structurally created on September 30, 2025. Current chart dynamics suggest the Nirvana zone is likely to emerge around $240, which will become a long-term reference point.
Also worth noting: starting from Phase 4, the stock has been forming its monthly Adhishthana Cakra, and is now trading near the upper arc of this structure. According to the framework, the underlying trades in this range with a breakout emerging in Phase 9. Considering this and the fact that Phase 10 is approaching maturity on the weekly chart, signs of exhaustion may emerge soon.
<h3 class="wp-block-heading">Investor Outlook: Hold with Caution, Avoid New Entries for Now</h3>
For existing investors, the strategy is to hold while closely monitoring the weekly chart for ALNY signs of a structural breakdown. A clear break would signal the beginning of the descent phase- the "Wrath of Ganga" in Adhishthana terminology, bringing the stock back toward its Nirvana level.
For potential entrants, Phase 10 is not an ideal entry zone, especially with the stock trading near the higher arc of the monthly Adhishthana Cakra. Chasing the momentum at this point would offer poor risk-reward dynamics.

Equities

Technicals

Opinion

Signals

Trading Ideas

ALNY

Alnylam Pharma Stock Outlook: Is ALNY Topping Out?

News

Financing

DDC Enterprise Announces Closing Of Aggregate Of $528M Capital Raise With Anson Funds

Premier League selects Microsoft as the official cloud and AI partner for its digital platforms; together the companies will transform the fan experience with AI

Sports

General

MSFT

Premier League And Microsoft Anbounce Five-Year Strategic Partnership To Use AI To Personalize Fan Experience

Planet Labs Germany GmbH, a leading provider of daily data and insights about Earth, today announced a multi-year €240 million agreement, funded by the German government, in support of European peace and security. Through the agreement, Planet will provide dedicated capacity and direct downlink services on Pelican satellites over specific European regions. This deal also includes access to PlanetScope and SkySat data, along with AI-enabled solutions for enhanced situational awareness and maritime domain awareness.
This contract will leverage satellites already under development. Planet expects to begin recognizing revenue in January 2026, ramping up over several years. As a result, Planet is not updating its previously issued financial guidance for this fiscal year, which was provided on June 4, 2025.
 &nbsp;

Planet Labs Germany Announces Multi-Year €240M Agreement, Funded By German Government, In Support Of European Peace And Security

Wells Fargo analyst Colin Langan maintains Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) with a Equal-Weight and raises the price target from $37 to $38.

Price Target

Analyst Ratings

Wells Fargo Maintains Equal-Weight on Magna International, Raises Price Target to $38

WIIM

Planet Labs shares are trading higher after the company won a €240 million satellite services deal funded by the German government.

Baird analyst Michael Bellisario maintains Hyatt Hotels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>) with a Neutral and raises the price target from $146 to $148.

Baird Maintains Neutral on Hyatt Hotels, Raises Price Target to $148

<a href="https://www.globenewswire.com/Tracker?data=pMwGRFG9ZHr9bc2OL_IaDKid2OBkqGRnEJyMy7BLDncZ6TR0hBUQsTAMmUk74GY1t2IU8XIeZLDnx0ufawL0UTfGOMHKPvb5f3Bmc5rAfJY=">Varonis Systems, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>), a leader in data security, today announced a strategic partnership with Microsoft to help secure the next generation of workplace AI.
The companies will build upon <a href="https://www.globenewswire.com/Tracker?data=YRiukOwie6AbONabA79p50OAW49O3ZQJPG1jPP2xKmsWEaho3-MjBPVnVfsAmw9WKoC_lvwuZ-GtEFNSZ63jVpSuaGaKWHpD3BfW6p-2vQ466kpSGju16d_8VLP1HnpTWC_9V_CxHU4sSlX6uIZQkg==">existing product innovations</a> that help organizations securely adopt Microsoft Copilot. The partnership will also deepen the integration between the Varonis Data Security Platform and Microsoft's security portfolio — including Microsoft Purview — to deliver automated protection for sensitive data across the Microsoft ecosystem and beyond.
The agreement lays out an engineering-led plan to solve one of the foundational challenges of the AI era — preventing AI tools, agents, and LLMs from accessing unauthorized data.

VRNS

Varonis Systems Partners With Microsoft To Help Secure Next Gen Of Workplace AI

Contracts

Planet Wins €240M Satellite Services Deal, Funded By German Government

Wells Fargo analyst Colin Langan maintains Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>) with a Equal-Weight and raises the price target from $100 to $103.

Wells Fargo Maintains Equal-Weight on Lear, Raises Price Target to $103

Biotech

STXS

Stereotaxis Publishes First Clinical Results From MAGiC Catheter Study In Journal of Interventional Cardiac Electrophysiology

Buybacks

EXFY

Expensify Says Repurchased 1,285,336 Shares

RVSB

Riverview Bancorp Joins Russell 2000 Index

SAIL

SailPoint Added To Broad-Market Russell 3000 Index

Wells Fargo analyst Colin Langan maintains BorgWarner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) with a Overweight and raises the price target from $44 to $45.

Wells Fargo Maintains Overweight on BorgWarner, Raises Price Target to $45

Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) <a target="_blank" href="https://www.benzinga.com/topic/amd" rel="noreferrer noopener">stock surged nearly</a> 38% in the last three months, buoyed by the AI frenzy. PHLX Semiconductor Index (SOX), of which AMD is also a constituent, generated 30% returns during the period.
AMD&#8217;s returns also topped the S&amp;P 500&#8217;s 11% and the Nasdaq Composite&#8217;s 18% during the period.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45928757/amd-serious-ai-contender-with-sights-on-over-500-billion-tam-billions-in-revenue-analyst" rel="noreferrer noopener">AMD &#8216;Serious AI Contender&#8217; With Sights On Over $500 Billion TAM, Billions In Revenue: Analyst</a>
On Monday, Cathie Wood&#8216;s Ark Invest executed significant portfolio adjustments, <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/06/46186154/cathie-woods-monday-moves-loads-up-on-amd-stock-lightens-coinbase-crypto-bet" target="_blank" rel="noreferrer noopener">prominently acquiring shares</a> of AMD.
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46113083/amd-taiwan-semiconductor-manufacturing-cnbc-final-trades" target="_blank" rel="noreferrer noopener">Last week, on</a> CNBC&#8217;s &#8220;Halftime Report Final Trades,&#8221; Jason Snipe preferred AMD, emphasizing that Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) isn&#8217;t the only strong chip stock.
In May, AMD reported <a href="https://www.benzinga.com/news/earnings/25/05/45237261/amd-q1-earnings-revenue-eps-beat-driven-by-expanding-data-center-ai-momentum-chipmaker-expects-strong-growth-in-2025" target="_blank" rel="noreferrer noopener">first-quarter revenue</a> of $7.44 billion, a 36% year-over-year increase, surpassing analyst estimates of $7.13 billion. This was driven by the strength of its core businesses, the expansion of its data center, and the momentum of AI. The chipmaker reported first-quarter adjusted earnings of 96 cents per share, beating analyst estimates of 94 cents per share. The gross margin came in at 54% for the quarter.
AMD expects second-quarter revenue of approximately $7.4 billion, plus or minus $300 million. Analysts are currently forecasting second-quarter revenue of $7.24 billion.
AMD anticipates a second-quarter adjusted gross margin of 43%, reflecting an $800 million impact from inventory charges resulting from the U.S. government&#8217;s export controls.
AMD has a <a target="_blank" href="https://www.benzinga.com/quote/AMD/analyst-ratings" rel="noreferrer noopener">consensus price target</a> of $141.09 based on the ratings of 38 analysts. The high is $200 issued by Rosenblatt on June 13, 2025. With an average price target of $163.33 between Melius Research and Piper Sandler, there&#8217;s an implied 16.78% upside for AMD from these most recent analyst ratings.
In May, Bank of America Securities analyst Vivek Arya projected that AMD <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45548891/amd-could-see-eps-upside-by-2027-despite-nvidias-over-80-market-share-analyst">would gain share</a> through server and PC CPU growth, AI momentum, and a $10 billion Middle East contract pipeline.
Even though Arya expects Nvidia (80%+ share) and custom chips (10–15%) to dominate, he sees AMD capturing 3–4% of the $300 billion–$400 billion AI accelerator market.
Arya views AMD&#8217;s valuation as compelling and expects $6.6 billion in sales upside by 2027, supported by strong execution and a $6 billion buyback boost.
In June, Arya projected <a href="https://www.benzinga.com/markets/tech/25/06/45855187/nokia-taps-amd-processors-to-power-next-gen-5g-networks">strong second-quarter</a> momentum for AMD, driven by higher-priced new products and potential seasonal strength in the second half.
Price Action: AMD stock traded lower by 2.46% to $138.44 premarket at Tuesday&#8217;s last check.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46109917/billionaire-david-tepper-dumps-nvidia-slashes-magnificent-7-holdings-but-bets-big-on-these-2-ai-and-blockchain-plays" target="_blank" rel="noreferrer noopener">Billionaire David Tepper Dumps Nvidia, Slashes &#8216;Magnificent 7&#8217; Holdings — But Bets Big On These 2 AI And Blockchain Plays</a></li>
</ul>
Photo: Shutterstock

Tech

NVDA

AMD Blows Past S&P And Nasdaq — Is This Just The Beginning?

Across the recent three months, 14 analysts have shared their insights on Sweetgreen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $21.0, with a high estimate of $30.00 and a low estimate of $15.00. A 22.48% drop is evident in the current average compared to the previous average price target of $27.09. 
<img src="https://www.benzinga.com/files/images/story/2025/1751374909_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Sweetgreen among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anthony Trainor</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$19.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Charles</td>
<td>TD Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$15.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Rahul Krotthapalli</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Anthony Trainor</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$19.00</td>
<td>-</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$15.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Andrew Charles</td>
<td>TD Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$25.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Rahul Krotthapalli</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$23.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Brian Bittner</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$29.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Brian Harbour</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$22.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Brian Mullan</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Rahul Krotthapalli</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Sweetgreen. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Sweetgreen compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Sweetgreen's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Sweetgreen's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/SG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Sweetgreen analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Sweetgreen</h2>
Sweetgreen Inc is a mission-driven, next-generation restaurant and lifestyle brand that serves healthy food at scale. Its bold vision is to be as ubiquitous as traditional fast food, but with the transparency and quality that consumers increasingly expect. It is creating plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing.
<h3>Sweetgreen's Economic Impact: An Analysis</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Positive Revenue Trend: Examining Sweetgreen's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.36% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Sweetgreen's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -15.06%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -5.7%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Sweetgreen's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -2.96%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Sweetgreen's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.76.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sweetgreen Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)

Ratings for Emerson Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) were provided by 17 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">6</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $125.94, a high estimate of $155.00, and a low estimate of $99.00. This current average reflects an increase of 1.66% from the previous average price target of $123.88. 
<img src="https://www.benzinga.com/files/images/story/2025/1751374899_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The analysis of recent analyst actions sheds light on the perception of Emerson Electric by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ken Newman</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$155.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Ken Newman</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$118.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$146.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$112.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$121.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$133.00</td>
<td>$113.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$133.00</td>
<td>$127.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$127.00</td>
<td>$119.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$124.00</td>
<td>$123.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$104.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$121.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$130.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$119.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$99.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$110.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Ken Newman</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$125.00</td>
<td>$158.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Emerson Electric. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Emerson Electric compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Emerson Electric's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Emerson Electric's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EMR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Emerson Electric analyst ratings.</a>
<h2>Delving into Emerson Electric's Background</h2>
Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands. Emerson organizes its business into seven segments that sell a wide range of automation software, power tools, and automation hardware such as valves, gauges, and switches. In recent years, Emerson divested its climate technology and consumer businesses to become more of a pure-play industrial automation company. The automation of a factory is an enticing long-term proposition for manufacturers, helping reduce accident rates and raise uptime and productivity.
<h3>Emerson Electric's Financial Performance</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Positive Revenue Trend: Examining Emerson Electric's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.28% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Emerson Electric's net margin is impressive, surpassing industry averages. With a net margin of 10.94%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Emerson Electric's ROE excels beyond industry benchmarks, reaching 2.44%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Emerson Electric's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.15% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Emerson Electric's debt-to-equity ratio surpasses industry norms, standing at 0.77. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Emerson Electric Through 17 Analysts

IMCC

IM Cannabis To Take Reasonable Measures To Regain Nasdaq Compliance

During the last three months, 10 analysts shared their evaluations of Adient (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADNT#NYSE">ADNT</a>), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $15.25, a high estimate of $18.00, and a low estimate of $13.00. Observing a downward trend, the current average is 7.24% lower than the prior average price target of $16.44. 
<img src="https://www.benzinga.com/files/images/story/2025/1751374883_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Adient among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>John Murphy</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$17.50</td>
<td>$15.00</td>
</tr>
<tr>
<td>Adam Jonas</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$16.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$17.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Joseph Spak</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$15.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$14.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$14.00</td>
<td>-</td>
</tr>
<tr>
<td>John Murphy</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$15.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Joseph Spak</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Adient. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Adient compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Adient's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Adient's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ADNT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Adient analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About Adient</h2>
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion but will likely be below $14 billion in fiscal 2025 on tariff interruptions and divesting some lower-quality business.
<h3>Adient's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3M period, Adient faced challenges, resulting in a decline of approximately -3.71% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Adient's net margin excels beyond industry benchmarks, reaching -9.28%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Adient's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -18.99%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -3.91%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Adient's debt-to-equity ratio surpasses industry norms, standing at 1.45. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADNT

Analyst Expectations For Adient's Future

Press Releases

Dingdong to Report Second Quarter 2024 Financial Results on August 7, 2024

Earnings

Dingdong (Cayman) Limited Announces Second Quarter 2024 Financial Results

Dingdong to Report Third Quarter 2024 Financial Results on November 6, 2024

Dingdong (Cayman) Limited Announces Third Quarter 2024 Financial Results

Dingdong to Report Fourth Quarter 2024 Financial Results on March 6, 2025

Dingdong Announces US$20.0 Million Share Repurchase Program

Dingdong (Cayman) Limited Announces Fourth Quarter 2024 Financial Results

Dingdong Files Its Annual Report on Form 20-F

Dingdong to Report First Quarter 2025 Financial Results on May 16, 2025

Dingdong (Cayman) Limited Announces First Quarter 2025 Financial Results

Albertsons Companies, Inc. Class A Common Stock

Albertsons Companies

Caseys General Stores, Inc. - Common Stock

Casey's General Stores

Chanson International Holding - Class A Ordinary Shares

Chanson International

Grocery Outlet Holding Corp. - Common Stock

Grocery Outlet Holding

Ingles Markets, Incorporated - Class A Common Stock

Ingles Markets

Kroger

Maison Solutions Inc. - Class A Common Stock

Maison Solutions

Natural Grocers by Vitamin Cottage, Inc. Common Stock

Natural Grocers

Reborn Coffee

Sprouts Farmers Market, Inc. - Common Stock

Sprouts Farmers Market

BBB Foods

Village Super Market, Inc. - Class A Common Stock

Village Super Market

WEBUY GLOBAL LTD. - Class A Ordinary Shares

Webuy Global

Weis Markets

Meiwu Technology Company Limited - Ordinary Shares

Comments

Dingdong (Cayman)

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL